Elicityl
PrivateLast Round
VC Round
Sep 27, 2015
Company Overview
Elicityl is a biotechnology company that specializes in the design, manufacturing, and supply of bioactive oligosaccharides, polysaccharides, and glycoconjugates for applications in human health, animal nutrition, and plant health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elicityl Comparables
Compare Elicityl with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sussex Research Laboratories Inc. | 84% | |
| zuChem, Inc. | 84% | |
| ICE Pharma | 79% | |
Elicityl Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 27, 2015 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Monthly visitors grew 69% MoM, reaching 3.9K.
- Apr 13, 2025
Monthly visitors grew 353% MoM, reaching 1.8K.
Elicityl Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elicityl's valuation, stock price, and market status.